Gerald Appel, MD, Dana V. Rizk, MD - Advancements in IgA Nephropathy: Discovering the Potential of Complement Pathway Therapies

This content has been developed for healthcare professionals only.
Patients who seek health information should consult with their
physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides,
and complete CME information, and to apply for credit, please
visit us at PeerView.com/XJK865. CME credit will be available
until February 25, 2026.


Advancements in IgA Nephropathy: Discovering the Potential of
Complement Pathway Therapies


Purdue University College of Pharmacy, an equal access/equal
opportunity institution, is accredited by the Accreditation
Council for Continuing Medical Education (ACCME) to provide
continuing medical education for physicians.


This accredited activity has been developed in collaboration with
our educational partner, PVI, PeerView Institute for Medical
Education.


SupportThis activity is supported by an
educational grant from Novartis Pharmaceuticals Corporation.


Disclosure information is available at the beginning of the video
presentation.